Simultaneous and Rapid Determination of Six Tyrosine Kinase Inhibitors in Patients with Non-Small Cell Lung Cancer Using HPLC-MS/MS

Figure 1

Product ion chromatograms and fragment structures of six TKIs. (a) Gefitinib. (b) Afatinib. (c) Erlotinib. (d) Crizotinib. (e) Osimertinib. (f) Icotinib. (g) Carbamazepine (IS).

(a)

(b)

(c)

(d)

(e)

(f)

(g)